{ event: "article_read", name: `EMPOWER Study in Saudi Arabia`, author: ``, tags: `Diabetes`, publication_date: ``, interaction_type: "content" } 
Read article Read article
EMPOWER Study in Saudi Arabia
Key highlights from the EMPOWER Study in Saudi Arabia
Related articles
Glargine 300 use in people with type 2 diabetes who fast during Ramadan
Watch Professor Mohamed Hassanein, consultant endocrinologist in Dubai Hospital, Dubai Health Authority and the chair of Diabetes and Ramadan International Alliance shedding the light on what are the unmet needs amongst Muslims with Type 2 diabetes when fast during Ramadan.
.jpg/jcr:content/image%20(10).jpg)
Advancing Therapy with iGlarLixi: Differentiation from other complex regimens
An educational video outlining key data from indirect comparisons of iGlarLixi versus IDegAsp.
MAT-BH-2400507/v1/MAR2025